Search research articles
Contact Us
Filters
Showing results (11-20 of 127) with videos related to
Page
of 13
Sort By:
Future Medicinal Chemistry
|
March 24, 2011
Direct-to-consumer advertising of prescription medicines: a counter argument
Barbara Mintzes, Dee Mangin
American Family Physician
|
January 3, 2019
Deprescribing Is an Essential Part of Good Prescribing
Barbara Farrell, Dee Mangin
Therapeutic Advances in Drug Safety
|
November 2, 2019
Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use
Dee Mangin, Doron Garfinkel
BMJ (Clinical Research Ed.)
|
October 4, 2019
Clinical judgments, not algorithms, are key to patient safety-an essay by David Healy and Dee Mangin
David Healy, Dee Mangin
BMJ (Clinical Research Ed.)
|
March 24, 2007
Urinary tract infection in primary care
Dee Mangin, Les Toop
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
June 7, 2007
The Quality and Outcomes Framework: what have you done to yourselves?
Dee Mangin, Les Toop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 16, 2019
Gabapentin misuse
Robin Lennox, Dee Mangin
BMJ (Clinical Research Ed.)
|
December 8, 2007
Quality and outcomes framework. Evidence of net benefit is lacking
Les J Toop, Dee Mangin
The New Zealand Medical Journal
|
December 18, 2012
Direct-to-consumer genetic testing: letting the genie out of the bottle?
Dee Mangin, Ben Hudson, Les Toop
BMJ (Clinical Research Ed.)
|
June 15, 2012
Beyond diagnosis: rising to the multimorbidity challenge
Dee Mangin, Iona Heath, Marc Jamoulle
Page
of 13
Search research articles
Search
Showing results (11-20 of 127) with videos related to
Sort By:
Page
of 13
Future Medicinal Chemistry
|
March 24, 2011
Direct-to-consumer advertising of prescription medicines: a counter argument
Barbara Mintzes, Dee Mangin
American Family Physician
|
January 3, 2019
Deprescribing Is an Essential Part of Good Prescribing
Barbara Farrell, Dee Mangin
Therapeutic Advances in Drug Safety
|
November 2, 2019
Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use
Dee Mangin, Doron Garfinkel
BMJ (Clinical Research Ed.)
|
October 4, 2019
Clinical judgments, not algorithms, are key to patient safety-an essay by David Healy and Dee Mangin
David Healy, Dee Mangin
BMJ (Clinical Research Ed.)
|
March 24, 2007
Urinary tract infection in primary care
Dee Mangin, Les Toop
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
June 7, 2007
The Quality and Outcomes Framework: what have you done to yourselves?
Dee Mangin, Les Toop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 16, 2019
Gabapentin misuse
Robin Lennox, Dee Mangin
BMJ (Clinical Research Ed.)
|
December 8, 2007
Quality and outcomes framework. Evidence of net benefit is lacking
Les J Toop, Dee Mangin
The New Zealand Medical Journal
|
December 18, 2012
Direct-to-consumer genetic testing: letting the genie out of the bottle?
Dee Mangin, Ben Hudson, Les Toop
BMJ (Clinical Research Ed.)
|
June 15, 2012
Beyond diagnosis: rising to the multimorbidity challenge
Dee Mangin, Iona Heath, Marc Jamoulle
Page
of 13